Co-Founder and Head of Business Development and Licensing, Affinia Therapeutics
Male
Robert Johnson is the Chief Executive Officer of Adrestia Therapeutics.
Headlines from Google News. Social posts load from the platform only when you open a tab.
Endpoints News · Nov 8
Cambridge Independent · Mar 10